Related content

Pharmacokinetics and metabolism of [¹⁴C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

By Furuta Shinji   Smart Clair   Hackett Andrew   Benning Rajdeep   Warrington Steve  

Xenobiotica, Vol. 43, Iss. 5, 2013-05 ,pp. : 432-442

Informa Healthcare

Access to resources Recommend Favorite

Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog

By Naitoh T.   Mishima M.   Kawaguchi S.   Matsui K.   Andoh T.   Kagei K.   Kakiki M.   Yuzuriha T.   Horie T.  

Xenobiotica, Vol. 27, Iss. 10, 1997-10 ,pp. : 1053-1070

Informa Healthcare

Access to resources Recommend Favorite

Metabolism and excretion of [¹⁴C]taranabant, a cannabinoid-1 inverse agonist, in humans

By Karanam Bindhu   Addy Carol   Bateman Thomas   Reddy Vijay Bhasker   Li Susie   Dean Dennis   Li Hankun   Jones Allen   Schenk David   Zhang Andy Shiqiang   Braun Matt   Freeman Amanda   Flach Stephen   Stoch Aubrey   Chodakewitz Jeff   Wagner John A.   Kumar Sanjeev  

Xenobiotica, Vol. 40, Iss. 10, 2010-10 ,pp. : 691-700

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the absorption, excretion and metabolism of [¹⁴C] etoperidone in man

By Caldwell G. W.   Wu W. N.   Masucci J. A.  

Xenobiotica, Vol. 31, Iss. 11, 2001-11 ,pp. : 823-839

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

By Kuhlmann Olaf   Paehler Axel   Weick Idelette   Funk Christoph   Pantze Michael   Zell Manfred   Timm Uwe  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 840-852

Informa Healthcare

Access to resources Recommend Favorite